Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ·Healthcare·Biotechnology
$3.79
+3.57%
Mkt Cap $1.65M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$7.00
Range $6.00 – $8.00
Implied Upside
+84.9%
Consensus $7.00 vs current $3.79
NASDAQ·Healthcare·Biotechnology
$3.79
+3.57%
Mkt Cap $1.65M
No recent rating data.
Price Target (2 analysts)
$7.00
Range $6.00 – $8.00
+84.9%
Consensus $7.00 vs current $3.79